Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

To determine the efficacy of soy/isoflavone supplementation on hot flashes in men who are being treated with luteinizing hormone-releasing hormone (LHRH) agonist therapy for control of advanced prostate cancer

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Kansas
• Collaborator: Amgen
• Treatments: Androgens

Criteria

Inclusion Criteria:

• Histologically proven adenocarcinoma of prostate with treatment of prostate cancer (radical prostatectomy, radiation therapy, etc.)

• had biochemical/clinical relapse and started on antiandrogens

• have documented history of hot flashes

Exclusion Criteria:

• History of MI, DVT, CVA

• peanut allergy

• untreated hypothyroidism

• must be off other medical treatment for hot flashes for 2 weeks before enrollment in this study